Evidence map›Paper›PMID 34857811›Full record

ArticleScientific reports2021

Changes in resting-state measures of prostate cancer patients exposed to androgen deprivation therapy.

Julio Plata-Bello, Ana Plata-Bello, Yaiza Pérez-Martín, David López-Curtis, Silvia Acosta-López, Cristián Modroño, Tomás Concepción-Massip

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Observational
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Julio Plata-BelloDepartment of Neurosurgery, Hospital Universitario de Canarias, CP 38320, S/C de Tenerife, Spain. jplabel@gobiernodecanarias.org.
Ana Plata-BelloDepartment of Urology, Hospital Universitario de Canarias, CP 38320, S/C de Tenerife, Spain.
Yaiza Pérez-MartínDepartment of Neurology, Hospital Universitario de Canarias, CP 38320, S/C de Tenerife, Spain.
David López-CurtisCognitive Neuroscience Research Group, University of La Laguna, S/C de Tenerife, Spain.
Silvia Acosta-LópezCognitive Neuroscience Research Group, University of La Laguna, S/C de Tenerife, Spain.
Cristián ModroñoDepartment of Physiology, Faculty of Medicine, University of La Laguna, CP 38320, S/C de Tenerife, Spain.
Tomás Concepción-MassipDepartment of Urology, Hospital Universitario de Canarias, CP 38320, S/C de Tenerife, Spain.
Hospital Universitario de Canarias · ESUniversidad de La Laguna · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present work is to describe the differences in rs-fMRI measures (Amplitude of low frequency fluctuations [ALFF], Regional Homogeneity [ReHo] and Functional Connectivity [FC]) between patients exposed to Androgen deprivation therapy (ADT) and a control group. Forty-nine ADT patients and fifteen PC-non-ADT patients (Controls) were included in the study. A neuropsychological evaluation and a resting-state fMRI was performed to evaluate differences in ALFF and ReHo. Region of interest (ROI) analysis was also performed. ROIs were selected among those whose androgen receptor expression (at RNA-level) was the highest. FC analysis was performed using the same ROIs. Higher ALFF in frontal regions and temporal regions was identified in Controls than in ADT patients. In the ROI analysis, higher activity for Controls than ADT patients was shown in the left inferior frontal gyrus and in the left precentral gyrus. Lower ALFF in the right hippocampus and the lateral geniculate nucleus of the right thalamus was identified for Controls than ADT patients. Higher ReHo was observed in Controls in the left parietal-occipital area. Finally, ADT patients presented an increase of FC in more regions than Controls. These differences may reflect an impairment in brain functioning in ADT users.

Indexed as

AgedAndrogen AntagonistsBrainBrain MappingCase-Control StudiesHumansMagnetic Resonance ImagingMaleNeuropsychological TestsProstatic NeoplasmsRestAndrogen Antagonists

Identifiers

PMID34857811
PMCPMC8639725
OpenAlexW3217233483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.